![]() |
市场调查报告书
商品编码
1930091
全球心血管保健品市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考量、未来预测(2026-2034)Cardiovascular Health Supplements Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
由于人们对心臟健康的日益关注以及心血管疾病在全球范围内的患病率不断上升,全球心血管保健品市场正经历着稳步增长。 根据 Fortune Business Insights 预测,2025 年市场规模预计将达到 123.1 亿美元,2026 年将成长至 130 亿美元。在预测期内,预计到 2034 年,市场规模将达到 215.1 亿美元,2026 年至 2034 年的复合年增长率 (CAGR) 为 6.50%。
北美地区引领心血管健康补充品市场,预计到 2025 年将占 40.98% 的市场占有率,这主要得益于人们健康意识的提高、预防医学的普及以及人口老化。
市场概览
心血管健康补充剂透过帮助控制胆固醇水平、血压和整体血管健康来支持心臟功能。 这些补充剂包括omega-3脂肪酸、鱼油、红曲、辅酶Q10 (CoQ10)、膳食纤维、固醇、亚麻仁油和各种草药萃取物。肥胖、不良饮食和缺乏运动等生活方式相关疾病的增加,显着提高了心臟病的风险,从而推动了对预防性营养解决方案的需求。
此外,老年人越来越关注心臟健康,他们希望透过高品质的传统和天然补充剂来降低心血管疾病併发症的风险,这也推动了市场的发展。
新冠疫情的影响
新冠疫情对心血管健康补充剂市场产生了正面影响。人们对免疫力和心臟健康的关注度提高,促使补充剂的消费量增加。疫情期间,由于心臟健康补充剂的需求增加,主要生产商的收入也实现了成长。即使在疫情结束后,由于人们对预防医学的持续关注,该市场仍保持着稳定成长。 保健品生产商加大广告和促销力度,也进一步推动了市场扩张。
市场趋势
消费者越来越倾向选择天然成分
最显着的趋势之一是消费者越来越偏好天然来源的心血管保健品。由于担心合成营养素的副作用,消费者越来越多地选择成分纯净、植物性和草本产品。天然保健品被认为较安全,适合长期服用,并有益于改善血液循环、提升精力水平和增强心臟功能。这种转变促使生产商推出采用天然配方的创新产品。
市场成长驱动因素
心血管疾病发生率上升
心血管疾病(包括心律不整、冠状动脉疾病、高血压和中风)发生率的上升是市场成长的主要驱动因素。久坐不动的生活方式和不健康的饮食习惯加剧了已开发国家和发展中国家心臟病负担的加重。 作为一项预防措施,每日服用心血管保健品的人数正在增加。
产品上市数量不断增加
随着膳食补充剂消费量的增长,老牌企业和新晋企业都在积极推出创新的心血管健康产品。製造商正在开发各种剂型的补充剂,包括胶囊、片剂和软糖,以涵盖更广泛的消费群。这种产品创新和供应量的增加正在推动市场成长。
限制因子
仿冒品的流通
儘管市场成长强劲,但假冒和贴错标籤的补充剂流通日益增多,给市场带来了挑战。消费者无法区分正品和仿冒品,限制了它们的普及。监管机构对贴错标籤的心臟健康补充剂的警告凸显了加强品质控制和消费者教育的必要性。
依类型
市场依类型分为天然补充剂和合成补充剂。
预计到2026年,天然补充剂将占市场主导地位,市占率达60.63%,主要得益于消费者对植物来源和草药成分的偏好。合成补充剂也占了相当大的市场占有率,这主要归功于其成本效益和临床研究的支持。
依成分
预计到2026年,维生素和矿物质将占42.23%的市场占有率,这主要得益于它们在维持血压、减轻发炎和改善血管功能方面的作用。其他成分,例如草药萃取物、ω-3脂肪酸和辅酶Q10,也越来越受到关注。
依剂型划分
由于胶囊剂型服用方便、吸收迅速且剂量选择多样,预计到2026年,胶囊剂型将以51.90%的市占率领先市场。片剂和软糖产品的市场接受度也在不断提高。
依通路划分
由于购买便利且消费者信任度高,药局和零售药局仍占分销主导地位。线上药局预计将因其便利性和电子商务渗透率的不断提高而稳步增长。
预计到2025年,北美地区的市场收入将达到50.5亿美元,凭藉较高的市场认知度和强大的製造商实力,将继续保持领先地位。欧洲地区将占较大占有率,这主要得益于消费者对植物补充剂的需求不断增长。亚太地区将受益于心血管疾病盛行率的上升和预防保健理念的日益普及,以实现快速成长。
The global cardiovascular health supplements market is witnessing steady growth due to rising awareness about heart health and the increasing prevalence of cardiovascular diseases worldwide. According to Fortune Business Insights, the market was valued at USD 12.31 billion in 2025 and is projected to grow to USD 13.0 billion in 2026. Over the forecast period, the market is expected to reach USD 21.51 billion by 2034, registering a CAGR of 6.50% from 2026 to 2034.
North America dominated the cardiovascular health supplements market with a 40.98% share in 2025, supported by high health awareness, strong preventive healthcare adoption, and a growing aging population.
Market Overview
Cardiovascular health supplements support heart function by helping manage cholesterol levels, blood pressure, and overall vascular health. These supplements include omega-3 fatty acids, fish oil, red yeast rice, Coenzyme Q10 (CoQ10), fiber, sterols, flaxseed oil, and various herbal extracts. Growing lifestyle-related health issues such as obesity, poor diet, and sedentary behavior have significantly increased the risk of heart disease, driving demand for preventive nutritional solutions.
The market is also benefiting from the rising focus of elderly populations on maintaining heart health through high-quality conventional and natural supplements, reducing the risk of complications related to cardiovascular diseases.
Impact of COVID-19
The COVID-19 pandemic had a positive impact on the cardiovascular health supplements market. Increased focus on immunity and heart health led to higher consumption of supplements. During the pandemic, key manufacturers experienced revenue growth due to rising adoption of heart health supplements. Post-pandemic, the market continues to grow steadily as awareness of preventive healthcare remains strong. Increased advertising and promotional campaigns by supplement manufacturers further support market expansion.
Market Trends
Increasing Shift Toward Natural Ingredients
One of the most prominent trends is the growing preference for natural cardiovascular health supplements. Consumers are increasingly choosing products with clean-label, plant-based, and herbal ingredients due to concerns about the side effects of synthetic nutrients. Natural supplements are perceived as safer for long-term consumption and beneficial for improving blood circulation, energy levels, and heart function. This shift is encouraging manufacturers to launch innovative products with natural formulations.
Market Growth Drivers
Rising Prevalence of Cardiovascular Diseases
The increasing incidence of cardiovascular conditions such as arrhythmia, coronary artery disease, hypertension, and stroke is a major driver of market growth. Sedentary lifestyles and unhealthy dietary habits are contributing to a rising burden of heart disease across both developed and developing regions. As a preventive approach, a growing number of individuals are incorporating cardiovascular supplements into their daily routines.
Increasing Product Launches
The growing consumption of dietary supplements has encouraged both established and new players to introduce innovative cardiovascular health products. Manufacturers are developing supplements in various dosage forms such as capsules, tablets, and gummies to attract a broader consumer base. This rising product innovation and availability are accelerating market growth.
Restraining Factors
Availability of Counterfeit Products
Despite strong growth, the market faces challenges from the increasing availability of counterfeit and misbranded supplements. The inability of consumers to distinguish between approved products and unauthorized supplements limits adoption. Regulatory warnings issued against misbranded heart health supplements highlight the need for stricter quality control and consumer education.
By Type
Based on type, the market is segmented into natural supplements and synthetic supplements.
The natural supplements segment dominated with a 60.63% share in 2026, driven by consumer preference for plant-based and herbal ingredients. The synthetic supplements segment also holds a notable share due to their cost-effectiveness and clinical research support.
By Ingredients
The vitamins & minerals segment dominated with a 42.23% market share in 2026, supported by their role in maintaining blood pressure, reducing inflammation, and improving vascular function. Herbal extracts and other ingredients such as omega-3 fatty acids and CoQ10 are also gaining traction.
By Dosage Form
The capsules segment led the market with a 51.90% share in 2026, owing to ease of consumption, quick absorption, and availability in multiple dosages. Tablets and gummies are also witnessing increasing adoption.
By Distribution Channel
Drug stores and retail pharmacies dominate distribution due to easy accessibility and consumer trust. Online pharmacies are expected to grow steadily due to convenience and expanding e-commerce penetration.
North America generated USD 5.05 billion in revenue in 2025, maintaining its leading position due to high awareness and strong manufacturer presence. Europe holds a significant share due to rising demand for plant-based supplements. Asia Pacific is witnessing rapid growth driven by increasing cardiovascular disease prevalence and growing acceptance of preventive healthcare.
Competitive Landscape
The market is fragmented, with key players including Amway, Thorne, Herbalife, Swisse Wellness, Gaia Herbs, and NOW FOODS. Companies are focusing on certifications, collaborations, and innovative product launches to strengthen their market position.
Conclusion
The global cardiovascular health supplements market, valued at USD 12.31 billion in 2025, is projected to reach USD 13.0 billion in 2026 and USD 21.51 billion by 2034. Rising cardiovascular disease prevalence, increasing preference for natural supplements, and continuous product innovation are expected to support market growth during the forecast period.
Segmentation
By Type
By Ingredients
By Dosage Form
By Distribution Channel
By Region